)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Nxera Pharma (4565) investor relations material
Nxera Pharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary31 Oct, 2025
Executive summary
Technology-driven biopharma focused on specialty medicines in neurology, metabolic, and immunology/GI, with global and local operations and a strong presence in Japan and APAC.
Over 400 employees, 20+ partnered programs, and 1,500 patents granted; listed on Tokyo Stock Exchange PRIME.
Reported revenue of JPY 21,848 million for the nine months ended September 30, 2025, a slight decrease of 0.6% year-over-year.
Core operating loss was JPY 986 million, compared to a core operating profit of JPY 4,425 million in the prior year.
Strategic acquisitions and partnerships have built a robust pipeline and recurring revenue streams.
Financial highlights
FY2025 product sales guidance: JPY 13.0–14.0bn (PIVLAZ®) and JPY 4.0–5.0bn (QUVIVIQ®) from royalty and supply.
Revenue from marketed products rose 37.8% to JPY 13,784 million, driven by PIVLAZ® and QUVIVIQ®.
R&D expenses up 36% YoY; SG&A down 1% YoY.
Core operating income posted a loss due to a YoY decline in milestone revenue, despite commercial sales growth.
Cost of sales increased by JPY 657 million, primarily from QUVIVIQ® launch costs.
Outlook and guidance
FY2025 objectives: JPY 17bn+ net product sales, in-license at least one late-stage medicine, execute a major partnership, and achieve positive operating profit if GPR52 option is exercised.
R&D expenses guided at JPY 12–14bn; S&M and G&A at JPY 15–17bn, with cost savings expected.
No consolidated financial results forecast due to unpredictability of milestone and partnership revenues.
Focus on maximizing sales and profit for PIVLAZ® and QUVIVIQ®, and expanding late-stage in-licensing.
Anticipates new partnerships, milestone payments, and expansion of drug discovery efforts.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Nxera Pharma earnings date
Jefferies London Healthcare Conference 202517 Nov, 2025
Next Nxera Pharma earnings date
Jefferies London Healthcare Conference 202517 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Sosei Group Corporation, also known as Sosei Heptares, is a biopharmaceutical company that specializes in the development of drugs using its proprietary G protein-coupled receptor (GPCR) targeted StaR technology and structure-based drug discovery (SBDD) platform. The company's product lineup includes medicines such as Ultibro, Seebri, Enerzair, Breezhaler, Pivlaz, and Oravi. Sosei Group Corporation is headquartered in Chiyoda-ku, Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage